Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study.

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

If you start taking the new weight-loss medications, be ready to stay with it for a long time, says Dr V Mohan, Chennai-based ...

Phentermine-topiramate helps with weight loss by suppressing appetite but may cause side effects like dizziness and mood changes. It's FDA approved for use with diet changes and increased physical ...

Do you know someone who's used drugs in an effort to lose weight? Research suggests that substance use aimed at weight loss ...

If you've googled "weight loss," there's a good chance that one of the first search results that came up was a website for Ozempic. But Ozempic hasn't been approved by the Food and Drug Administration ...

Share on Pinterest The U.S. obesity rate is declining as more people turn to GLP-1 drugs for weight loss. Bloomberg/Getty Images A new Gallup poll indicates that the rate of obesity among U.S. adults ...

The aerospace company was hurt by the delay of a new plane but made progress on increasing production of the 737 Max, its most popular aircraft. By Niraj Chokshi Boeing on Wednesday reported a big ...